vimarsana.com

Latest Breaking News On - Osama rahma - Page 1 : vimarsana.com

Risk of Side Effects from Cancer Immunotherapy Linked to Genetics

Risk of Side Effects from Cancer Immunotherapy Linked to Genetics
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Outcomes4Me Raises $12M in Series A Funding Round

Outcomes4Me Inc., a Cambridge, Mass.-based developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, raised $12m in Series A funding round. The round was led by Northpond Ventures, with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal Ltd, IRA Capital, and others. Andrea Jackson, a Northpond Ventures Director, will join Outcomes4Me’s board. The company intends to use the funds to extend its platform beyond breast cancer to other cancers, grow the platform’s regulatory-grade dataset, and expand to more patients in Europe.  Co-founded in 2017 by Maya R. Said, Sc. D., CEO, and Dr. Osama Rahma, Chief Medical Advisor, who were later joined by Chief Operating Officer Sami Shalabi, a former Google executive who sold his company to Google and co-founded and led Google Play Newsstand and the all-new Google News, growing both to over a billion users, Outcomes4Me has dev

Outcomes4Me sammelt 12 Millionen Dollar in einer überzeichneten Serie A, um die Expansion der KI-gestützten Plattform zur Stärkung von Krebspatienten voranzutreiben

Outcomes4Me sammelt 12 Millionen Dollar in einer überzeichneten Serie A, um die Expansion der KI-gestützten Plattform zur Stärkung von Krebspatienten voranzutreiben
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Outcomes4Me Raises $12M for AI-Powered Cancer Patient Empowerment Platform

Outcomes4Me Raises $12M for AI-Powered Cancer Patient Empowerment Platform What You Should Know: –  Outcomes4Me Inc., a Cambridge, MA-based developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, today announced it has raised $12 million in an oversubscribed Series A round led by Northpond Ventures, with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal Ltd, IRA Capital, and others. Andrea Jackson, a Northpond Ventures Director, will join Outcomes4Me’s board. – After experiencing first-hand the challenges of being a patient, Dr. Said, a former Senior Vice President and Global Head of Oncology Policy and Market Access at Novartis, co-founded Outcomes4Me in 2017, with the company’s Chief Medical Advisor, Dr. Osama Rahma, a National Institutes of Health (NIH)-trained practicing oncologist at Dana-Farber Cancer Institute and the Clinical Director of its Center f

Outcomes4Me sammelt 12 Millionen Dollar in einerüberzeichneten Serie A, um die Expansion der KI-gestützten Plattform zur Stärkung von Krebspatienten voranzutreiben

Outcomes4Me sammelt 12 Millionen Dollar in einerüberzeichneten Serie A, um die Expansion der KI-gestützten Plattform zur Stärkung von Krebspatienten voranzutreiben
mittelstandcafe.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mittelstandcafe.de Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.